Automated Mycoplasma Detection in Cell and Gene Therapies

This case study discusses the BIOFIRE® MYCOPLASMA test developed by bioMérieux for rapid mycoplasma detection in cell and gene therapy products. The assay offers results in approximately one hour, addressing the critical need for quick microbiological testing in advanced therapeutic medicinal products. It highlights the advantages of using this automated system over traditional culture methods, including reduced outsourcing costs and improved efficiency in ensuring patient safety.